SICHUAN BIOKIN PHARMACEUTICAL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 179.6 CNY | -3.21% |
|
-4.19% | +28.38% |
| Sales 2024 * | 6.13B 844M 70.39B | Sales 2025 * | 2.52B 346M 28.9B | Capitalization | 70.09B 9.64B 804B |
|---|---|---|---|---|---|
| Net income 2024 * | 3.45B 475M 39.6B | Net income 2025 * | 269M 37M 3.09B | EV / Sales 2024 * | 11.4 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 27.8 x |
| P/E ratio 2024 * |
20.9
x | P/E ratio 2025 * |
268
x | Employees | 2,086 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 11.83% |
More Fundamentals
* Assessed data
More news
| 1 day | -3.21% | ||
| 1 week | -4.19% | ||
| Current month | -0.99% | ||
| 1 month | +2.06% | ||
| 3 months | +50.24% | ||
| 6 months | +26.48% | ||
| Current year | +28.38% |
1 week
176.72
189.00
1 month
176.72215.71
Current year
96.21215.71
1 year
76.32215.71
3 years
28.75215.71
5 years
28.75215.71
10 years
28.75215.71
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/24/02 | 179.6 | -3.21% | 1,249,327 |
| 01/24/01 | 185.6 | +2.29% | 596,162 |
| 28/24/28 | 181.4 | -2.04% | 821,629 |
| 27/24/27 | 185.2 | -2.14% | 580,522 |
| 26/24/26 | 189.2 | +0.94% | 731,123 |
End-of-day quote Shanghai S.E., July 02, 2024
More quotes
Sichuan Biokin Pharmaceutical Co Ltd is a China-based company mainly engaged in drug research and development, production and marketing. The Company is mainly engaged in two business sectors: chemical preparations and Chinese patent medicine preparations, and innovative biological medicine business. The Company's main products include propofol emulsion injection, dexmedetomidine hydrochloride injection, medium/long chain fat emulsion injection, ribavirin granules and other chemical preparations, Chaihuang granules and other Chinese patent medicine preparations. The Company mainly conducts its business in the domestic market.
Sector
Pharmaceuticals
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
179.6
CNY
Average target price
226
CNY
Spread / Average Target
+25.84%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +28.38% | 9.9B | |
| +55.55% | 816B | |
| +39.12% | 634B | |
| -6.83% | 351B | |
| +17.15% | 323B | |
| +7.09% | 293B | |
| +13.42% | 238B | |
| +1.06% | 222B | |
| +13.61% | 218B | |
| +7.87% | 167B |
- Stock Market
- Equities
- 688506 Stock
